KMH-233 |
Catalog No.GC61845 |
KMH-233, un inhibidor potente, reversible y selectivo del transportador 1 de aminoÁcidos de tipo L (LAT1), inhibe la absorciÓn del sustrato de LAT1, la l-leucina (IC50 = 18 μM), asÍ como el crecimiento celular. KMH-233 potencia significativamente la eficacia de Bestatin y Cisplatin incluso en concentraciones bajas (25 μM).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1941174-13-5
Sample solution is provided at 25 µL, 10mM.
KMH-233, a potent, reversible and selective l-type amino acid transporter 1 (LAT1) inhibitor, inhibits the uptake of LAT1 substrate, l-leucin (IC50=18 µM) as well as cell growth. KMH-233 significantly potentiates the efficacy of Bestatin and Cisplatin even at low concentrations (25 µM)[1].
KMH-233 is able to inhibit binding and transport of essential neutral amino acids and thus, inhibit the cell growth of cancer cells[1].KMH-233 shows a significant reduction of cell growth with an IC50 of 124 µM[1].KMH-233 is effective and able to potentiate the anti-proliferative efficacy of Bestatin (100 µM) and Cisplatin (100 µM) at a lower concentration of 25 µM, inhibiting cell growth 53% and 50%, respectively[1].
References:
[1]. Huttunen KM, et al. A Selective and Slowly Reversible Inhibitor of l-Type Amino Acid Transporter 1 (LAT1) Potentiates Antiproliferative Drug Efficacy in Cancer Cells. J Med Chem. 2016;59(12):5740-5751.
Average Rating: 5
(Based on Reviews and 19 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *